undamentalytics Newsletter

Sangrix Inc. key statistics and ratios

In fiscal 2025, Sangrix Inc. had an operating margin of -7574.9% and a current ratio of 9.50. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Sangrix Inc.: financial ratios, annual
Fiscal year2017Jun 20172018Jun 20182019Jun 20192020Jun 20202021Jun 20212022Jun 20222023Jun 20232024Jun 20242025Jun 2025
Gross margin8.0%9.5%8.7%8.4%3.7%−72.9%−72.9%−32.7%100.0%
Operating margin5.6%7.0%−0.5%−14.2%−4.3%−452.1%−452.1%−513.6%<−999%
Net margin3.9%3.7%4.4%−20.1%−56.7%51.7%−450.7%−607.0%<−999%
Free-cash-flow margin−4.0%−3.6%−5.3%−27.3%—−360.0%−109.8%−274.5%<−999%
Return on equity24.2%31.2%22.6%−20.2%—20.6%−125.6%——
Return on assets—11.2%10.3%−8.5%−87.5%8.5%−116.9%−175.1%−127.9%
Asset turnover—3.002.330.421.540.170.260.290.01
Current ratio—1.722.001.540.8479.771.382.689.50
Debt to equity0.0%35.0%25.3%35.0%——20.5%——
Interest cover (operating income ÷ interest)5.3x5.5xn/mn/mn/mn/mn/mn/mn/m
Effective tax rate26.3%15.9%———————
Capital spending as % of revenue0.0%0.1%0.0%2.9%—132.6%1.8%0.0%0.0%
Free cash flow ÷ net income−102.9%−97.8%−121.2%——−695.8%———

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: SGRX vs SNTGMI vs SGRXDCM vs SGRX

More: Diversified Financial Services stocks compared, Financials sector, rankings of US companies

Figures from Sangrix Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Sangrix Inc.